UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014955
Receipt number R000017398
Scientific Title A prospective study for laparoscopic low anterior resection of rectum with lateral pelvic lymph node dissection in patients with advanced lower rectal cancer
Date of disclosure of the study information 2014/09/01
Last modified on 2016/11/16 11:13:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective study for laparoscopic low anterior resection of rectum with lateral pelvic lymph node dissection in patients with advanced lower rectal cancer

Acronym

laparoscopic lateral pelvic lymph node dissection in patients with advanced lower rectal cancer

Scientific Title

A prospective study for laparoscopic low anterior resection of rectum with lateral pelvic lymph node dissection in patients with advanced lower rectal cancer

Scientific Title:Acronym

laparoscopic lateral pelvic lymph node dissection in patients with advanced lower rectal cancer

Region

Japan


Condition

Condition

advanced lower rectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of laparoscopic lateral lymph node dissection in patients with advanced lower rectal cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

incidence of complication

Key secondary outcomes

3-year local recurrence-free survival,3-year recurrece-free survival,recurrence-free survival,overall survival,operative time,intraoperative bleeding,transition to open surgery,completion of surgery, number of dissected lateral lymph node, voiding dysfunction, hospital days after surgery


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

laparoscopic lateral pelvic lymph node dissection

Interventions/Control_2

lateral lymph node dissection by open surgery

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Histologically confirmed adenocarcinoma
(2)recquirement to all of follows by preoperative diagnostic imaging
1.invasion depth is more than T3, or metastasis in N1, N2 lymph node
2.Main lesion of the tumor is located at the rectum
3.Lower tumor margin is below the peritoneal reflection
4.No extramesorectal lymph node swelling (Shorter diameter is less than 10 mm)
5.No invasion to other organ (s)
(3) no past history of pelvic radiation
(4)without multiple malignancies
(5)Patient age is more than 20 and less than 75
(6)PS: 0, 1
(7)adequate organ function
(8) Written informed consent

Key exclusion criteria

1.Multiple malignancies to be treated
2.Pregnant women, possibly pregnant women, wishing to become pregnant, and nursing mothers.
3.Intestinal bleeding, ileus, bowel obstruction or uncontrolled peptic ulcer
4.Uncontrolled severe complications(DM, hypertension, diarrhea, et al.)
5.Massive pleural effusion or ascites that required drainage.
6.Patient with symptomatic cardiovascular disease or asymptomatic disease but has been treated (>=Grade 2 according to NCI-CTCAE ver.4). History of myocardial infarction within a year.
7.With interstitial lung disease or pulmonary fibrosis
8.Continuous systemic steroid therapy (oral or intravenous administration)
9.A history and/or current evidence of significant neurological and/or mental illness
10.Not appropriate for the study at the physician's assessment

Target sample size

22


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Kinoshita

Organization

Aichi Prefectural cancer center

Division name

Colorectal Surgery Division

Zip code


Address

1-1 Kanokoden Chikusa-ku, Nagoya, Aichi

TEL

052-762-6111

Email

t-kinoshita@h2.dion.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tetsuya Wada

Organization

M's system

Division name

data center

Zip code


Address

4902-1-5-D Hirokute Asahimae-cho Owariasahi Aichi

TEL

0561-51-5590

Homepage URL


Email

marobon@dream.com


Sponsor or person

Institute

Chubu Clinical Oncology Group

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 08 Month 26 Day

Last modified on

2016 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017398


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name